Car Sales Still Spe...
Health Care: Health Services
Exactech Inc. (EXAC: NASDAQ)
$15.12 -0.13 | -0.85%
06/04/12 - 12:06 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 15.25 |
| 52 Week High | 19.00 |
| 52 Week Low | 12.90 |
| Avg. Daily Vol. (Mil) | 0.02 |
| Beta (3 year) | 0.95 |
| Share Related Items | |
| Mkt Cap (Mil) | 200.91 |
| Shares Out (Mil) | 13.17 |
| Float (Mil) | 8.58 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.90 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.30 |
| Total Debt / Equity | 0.31 |
| Valuation Ratios | |
| Price Earnings | 21.80 |
| Price/Sales | 0.95 |
| Price/Book | 1.25 |
| Price/Cash Flow | 7.80 |
| Per Share Data | |
| Earnings | 0.70 |
| Sales | 15.99 |
| Book Value | 12.16 |
| Cash Flow | 1.95 |
| Business Summary | |
|---|---|
| Exactech, Inc. develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. | |
| General Information | |
| 2320 NW 66th Court
Gainesville, FL 32653 |
|
| www.exac.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 574 | |
| CEO: Dr. William Petty,M.D. | |
| Short Interest | |
| Current Month (Mil) | 0.24 |
| Previous Month (Mil) | 0.23 |
| Short Interest Ratio (Days) | 11.70 |
| Management Effectiveness | |
| Return on Equity | 5.70 |
| Return on Assets | 3.80 |
| Return on Investments | 4.40 |
| Profitability | |
| Gross Margin | 69.40 |
| EBIT Margin | 7.30 |
| Profit Margin | 4.30 |
Portfolios with EXAC
- Portfolio NameUser Type
- UserDustin
- UserRick's 401K
- Userljc
- UserPART 3 JPMorgan 27th Annual...
- UserCP2201 Portfolio 1
- UserJuly, Aug, Sept 08 Conferen...
- UserHorizon II
- Usercat3rn
- UserGowest 2
- Usersmall but interesting
Latest EXAC Headlines from TheStreet
- Exactech's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 01:05 pm
- Exactech's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.29.12 | 04:02 pm
- Exactech Inc. Stock Upgraded (EXAC) 02.23.12 | 04:02 am
- Exactech's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 01:11 pm
- Exactech Inc. Stock Downgraded (EXAC) 08.23.11 | 07:08 am
- Exactech Stock Soars (EXAC) 08.09.11 | 04:08 pm
- Exactech's CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.03.11 | 03:08 pm
- Exactech Inc. Stock Upgraded (EXAC) 06.01.11 | 07:06 am
- Exactech CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.04.11 | 03:05 pm
- Exactech CEO Discusses Q4 2010 - Earnings Call Transcript 02.28.11 | 11:02 am
Press Releases for EXAC
- Exactech Q1 Revenue Up 10% To $58.6 Million, Net Income $3.3 Million, Diluted EPS $0.25 - Business Wire 05.01.12 | 04:05 pm
- Exactech Schedules First Quarter 2012 Earnings Release And Conference Call - Business Wire 04.17.12 | 02:04 pm
- Exactech Announces Expiration Of Deferred Prosecution Agreement - Business Wire 03.15.12 | 12:03 pm
- Exactech 2011 Revenue Up 8% To $205M; Net Income $8.8M, EPS $0.67; Q4 Net Income $1.8M, EPS $0.14 - Business Wire 02.28.12 | 04:02 pm
- Exactech Announces $100 Million Long Term Syndicated Credit Facility - Business Wire 02.27.12 | 04:02 pm
- Exactech Announces Product Lineup For Exhibit At American Academy Of Orthopaedic Surgeons Meeting; Management To Present At Investor Conference - Business Wire 02.06.12 | 10:02 am
- Exactech Announces Preliminary 2011 Sales Of $205.4 Million And 4th Quarter 2011 Sales Of $53.1 Million - Business Wire 01.31.12 | 09:01 am
- Exactech To Present To Investors At The 2012 Noble Financial Equity Conference On January 17 - Business Wire 01.09.12 | 10:01 am
- Exactech Initiates Multi-Center Clinical Trial For New Cartilage Regeneration Technology - Business Wire 12.19.11 | 09:12 am
- Exactech Continues To Expand Spine Portfolio With Comprehensive Solution To Posterior Cervical Fusion - Business Wire 12.08.11 | 03:12 pm
Partner Headlines for EXAC
- Benchmark Initiates Coverage on Exactech with Buy Rating, $21 PT - Benzinga 05.18.12 | 09:05 am
- Exactech Underperforms in 4Q - Analyst Blog - Zacks 03.02.12 | 09:03 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.03.12 | 09:01 am
- Hanger's 3Q Mixed, View Lowered - Analyst Blog - Zacks 10.28.11 | 05:10 pm
- Hanger Retained at Neutral - Analyst Blog - Zacks 08.18.11 | 07:08 pm
- Exactech Expands Spine Biz - Analyst Blog - Zacks 06.01.11 | 07:06 pm
- Hanger Remains Outperform - Analyst Blog - Zacks 05.16.11 | 08:05 pm
- Hanger's EPS Meets, Profit Soars - Analyst Blog - Zacks 04.28.11 | 10:04 am
- Exactech 4Q EPS Meets, Rev Beats - Analyst Blog - Zacks 03.02.11 | 10:03 am
- Hanger Tops, Charges Hit Profit - Analyst Blog - Zacks 02.10.11 | 06:02 pm
